PLx Pharma Inc. (PLXP)

2.4400 -0.2200 (-8.27%) At close: 04:00PM EDT

PLx Pharma Inc.

9 Fishers Lane
Suite E
Sparta, NJ 07871
United States
973 409 6541
https://plxpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 16

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Michael J. Valentino	Exec. Chairman	393.75k	N/A	1954
Ms. Natasha Giordano	CEO, Pres & Director	884.88k	N/A	1960
Ms. Rita M. O'Connor CPA, CPA	CFO and Head of Manufacturing & Supply Chain	623.23k	N/A	1968
Mr. Ronald R. Zimmerman	Founder & Sr. Advisor	N/A	N/A	1953
Mr. Tom Long	VP of Manufacturing & Technical Operations	N/A	N/A	N/A
Ms. Janet M. Barth	VP of Investor Relations & Corp. Communications	N/A	N/A	N/A
Ms. Joanne Cotignola	VP of Marketing	N/A	N/A	N/A
Ms. Nicole Godino	National Sales Director	N/A	N/A	N/A
Mr. Patrick M. Lonergan	Member of Chief Exec. Officer Advisory Group	N/A	N/A	1935
Mr. Charles Edmund Sheedy C.F.A., CFA	Member of Chief Exec. Officer Advisory Group	N/A	N/A	1947

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Corporate Governance

PLx Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.